Masako Otsuki

436 total citations
31 papers, 350 citations indexed

About

Masako Otsuki is a scholar working on Pharmacology, Molecular Biology and Molecular Medicine. According to data from OpenAlex, Masako Otsuki has authored 31 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pharmacology, 14 papers in Molecular Biology and 14 papers in Molecular Medicine. Recurrent topics in Masako Otsuki's work include Antibiotics Pharmacokinetics and Efficacy (22 papers), Antibiotic Resistance in Bacteria (14 papers) and Cancer therapeutics and mechanisms (10 papers). Masako Otsuki is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (22 papers), Antibiotic Resistance in Bacteria (14 papers) and Cancer therapeutics and mechanisms (10 papers). Masako Otsuki collaborates with scholars based in Japan. Masako Otsuki's co-authors include T Nishino, Takeshi Nishino, Mayumi Tanaka, Tatsuya Ito, Tsutomu Une, M. Hosaka, Yoshie Takahashi, Nobuhisa Masuda, Akira Toyama and Masahiro Takahata and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and Postharvest Biology and Technology.

In The Last Decade

Masako Otsuki

29 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masako Otsuki Japan 13 211 154 107 88 40 31 350
L Xerri Italy 8 205 1.0× 307 2.0× 92 0.9× 130 1.5× 59 1.5× 27 474
Tomio Ohue Japan 6 227 1.1× 142 0.9× 162 1.5× 80 0.9× 46 1.1× 8 341
R. E. Buck United States 9 318 1.5× 194 1.3× 82 0.8× 114 1.3× 71 1.8× 16 452
G. Beskid United States 16 219 1.0× 184 1.2× 186 1.7× 111 1.3× 81 2.0× 35 531
G. C. Crumplin United Kingdom 8 193 0.9× 188 1.2× 222 2.1× 53 0.6× 48 1.2× 8 416
M Misiek United States 11 346 1.6× 226 1.5× 113 1.1× 102 1.2× 85 2.1× 26 497
N. Moreau France 8 192 0.9× 284 1.8× 174 1.6× 120 1.4× 89 2.2× 11 449
D. J. Merrikin United Kingdom 8 192 0.9× 135 0.9× 68 0.6× 73 0.8× 60 1.5× 13 327
Melvin Weinstein United States 6 199 0.9× 73 0.5× 115 1.1× 30 0.3× 37 0.9× 7 359
E. Schrinner Germany 14 361 1.7× 275 1.8× 115 1.1× 150 1.7× 127 3.2× 36 576

Countries citing papers authored by Masako Otsuki

Since Specialization
Citations

This map shows the geographic impact of Masako Otsuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masako Otsuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masako Otsuki more than expected).

Fields of papers citing papers by Masako Otsuki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masako Otsuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masako Otsuki. The network helps show where Masako Otsuki may publish in the future.

Co-authorship network of co-authors of Masako Otsuki

This figure shows the co-authorship network connecting the top 25 collaborators of Masako Otsuki. A scholar is included among the top collaborators of Masako Otsuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masako Otsuki. Masako Otsuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Otsuki, Masako & Takeshi Nishino. (2000). Report of Questionnaire Survey for Methicillin-resistant Staphylococcus aureus and Penicillin-resistant Streptococcus pneumoniae in the Kinki District. Kansenshogaku zasshi. 74(8). 658–663. 2 indexed citations
2.
Sakagawa, Eiko, et al.. (1998). In-vitro and in-vivo antibacterial activities of CS-834, a new oral carbapenem. Journal of Antimicrobial Chemotherapy. 42(4). 427–437. 14 indexed citations
3.
Tanaka, Masatoshi, Masako Otsuki, T Nishino, et al.. (1996). Mutation in DNA gyrase of norfloxacin-resistant clinical isolates of Neisseria gonorrhoeae.. Sexually Transmitted Infections. 72(4). 295–297. 12 indexed citations
4.
Hosaka, M., et al.. (1995). Antibacterial properties of AM-1155, a new 8-methoxy quinolone. Journal of Antimicrobial Chemotherapy. 36(2). 293–301. 35 indexed citations
5.
Nishino, Takeshi, et al.. (1994). In vitro and in vivo antibacterial activities of SY5555, a novel oral penem antibiotic. Chemotherapy. 42(1). 51–71. 5 indexed citations
6.
Nishino, Takeshi, et al.. (1994). In vitro and in vivo Antibacterial Activities of FK037, a New Parenteral Cephalosporin. Chemotherapy. 40(3). 167–182. 4 indexed citations
7.
Nishino, Takeshi, et al.. (1992). IN VITRO AND IN VIVO ANTIBACTERIAL ACTIVITIES OF MEROPENEM, A NEW CARBAPENEM ANTIBIOTIC. 40(1). 50–66. 1 indexed citations
8.
Tanaka, Mayumi, Masako Otsuki, & Takeshi Nishino. (1992). Bactericidal Activities of Ofloxacin and Its Optically Active Isomer (DR-3355) on Non-Growing Cells <i>of Escherichia coli </i>and <i>Pseudomonas aeruginosa</i>. Chemotherapy. 38(1). 21–27. 6 indexed citations
9.
Tanaka, Márcia Hiromi, Masako Otsuki, & T Nishino. (1992). In vitro and in vivo activities of DQ-2556 and its mode of action. Antimicrobial Agents and Chemotherapy. 36(12). 2595–2601. 6 indexed citations
10.
Otsuki, Masako, et al.. (1992). In vitro and in vivo antibacterial activities of E1077, a novel parenteral cephalosporin with a broad antibacterial spectrum. Antimicrobial Agents and Chemotherapy. 36(9). 1894–1901. 12 indexed citations
11.
Kawai, Yosuke, et al.. (1992). In vitro and in vivo antibacterial activities of meropenem, a new carbapenem antibiotic.. PubMed. 18(2). 37–46. 14 indexed citations
12.
Nishino, Takeshi, et al.. (1991). In Vitro and in Vivo Antibacterial Activity of Panipenem-Betamipron, a New Carbapenem Antibiotic. Chemotherapy. 39. 55–74. 1 indexed citations
13.
Nishino, T, et al.. (1991). In vitro and in vivo antibacterial activities of sparfloxacin, a new quinolone. Chemotherapy. 39. 59–77. 4 indexed citations
14.
Tomii, Yoshifumi, Kiyoshi Kimura, Jiro Segawa, et al.. (1991). In vivo evaluation of NM441, a new thiazeto-quinoline derivative. Antimicrobial Agents and Chemotherapy. 35(12). 2496–2499. 31 indexed citations
15.
Tanaka, Mayumi, Masako Otsuki, Tsutomu Une, & Takeshi Nishino. (1990). In-vitro and in-vivo activity of DR-3355, an optically active isomer of ofloxacin. Journal of Antimicrobial Chemotherapy. 26(5). 659–666. 37 indexed citations
16.
Nishino, Takeshi, et al.. (1987). Bacteriological Evaluation of 6315-S (Flomoxef), A New Oxacephem Antibiotic. Chemotherapy. 35(1). 57–75. 3 indexed citations
17.
Otsuki, Masako, et al.. (1979). BACTERIOLOGICAL STUDIES ON BACAMPICILLIN, A NEW ORALLY ACTIVE AMPICILLIN ESTER. 27(4). 7–16.
18.
Nakazawa, Shozo, et al.. (1974). Bacteriological studies on the combined action of aminoglycoside antibiotics and synthetic penicillins against Pseudomonas aeruginosa.. The Journal of Antibiotics. 27(12). 989–991. 4 indexed citations
19.
Nakazawa, Shozo, et al.. (1969). BACTERIOLOGICAL STUDY ON JOSAMYCIN. 17(4). 576–579. 1 indexed citations
20.
Nakazawa, Seshiru, et al.. (1969). [Bacteriological studies on rifampicin, a new antibiotic].. PubMed. 22(4). 276–86. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026